Annual Total Liabilities
$1.80 M
+$49.50 K+2.83%
December 31, 2023
Summary
- As of February 7, 2025, OGEN annual total liabilities is $1.80 million, with the most recent change of +$49.50 thousand (+2.83%) on December 31, 2023.
- During the last 3 years, OGEN annual total liabilities has fallen by -$37.70 thousand (-2.05%).
- OGEN annual total liabilities is now -80.96% below its all-time high of $9.45 million, reached on December 31, 2011.
Performance
OGEN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.13 M
+$743.20 K+53.73%
September 30, 2024
Summary
- As of February 7, 2025, OGEN quarterly total liabilities is $2.13 million, with the most recent change of +$743.20 thousand (+53.73%) on September 30, 2024.
- Over the past year, OGEN quarterly total liabilities has increased by +$328.30 thousand (+18.26%).
- OGEN quarterly total liabilities is now -77.49% below its all-time high of $9.45 million, reached on December 31, 2011.
Performance
OGEN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
OGEN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.8% | +18.3% |
| 3 y3 years | -2.0% | +18.3% |
| 5 y5 years | +54.0% | +18.3% |
OGEN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3.1% | at high | +134.0% |
| 5 y | 5-year | -28.7% | +3.1% | -19.9% | +134.0% |
| alltime | all time | -81.0% | +752.6% | -77.5% | +913.6% |
Oragenics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.13 M(+53.7%) |
| Jun 2024 | - | $1.38 M(+52.2%) |
| Mar 2024 | - | $908.70 K(-49.5%) |
| Dec 2023 | $1.80 M(+2.8%) | $1.80 M(+28.3%) |
| Sep 2023 | - | $1.40 M(+16.2%) |
| Jun 2023 | - | $1.21 M(-36.0%) |
| Mar 2023 | - | $1.89 M(+7.8%) |
| Dec 2022 | $1.75 M(+0.2%) | $1.75 M(+2.7%) |
| Sep 2022 | - | $1.70 M(+1.5%) |
| Jun 2022 | - | $1.68 M(+0.9%) |
| Mar 2022 | - | $1.66 M(-4.7%) |
| Dec 2021 | $1.74 M(-5.0%) | $1.74 M(-31.4%) |
| Sep 2021 | - | $2.54 M(+1.2%) |
| Jun 2021 | - | $2.51 M(+91.1%) |
| Mar 2021 | - | $1.32 M(-28.4%) |
| Dec 2020 | $1.84 M(-27.2%) | $1.84 M(+11.8%) |
| Sep 2020 | - | $1.64 M(-15.5%) |
| Jun 2020 | - | $1.94 M(-26.7%) |
| Mar 2020 | - | $2.65 M(+5.2%) |
| Dec 2019 | $2.52 M(+115.9%) | $2.52 M(-11.0%) |
| Sep 2019 | - | $2.83 M(+12.9%) |
| Jun 2019 | - | $2.51 M(+14.9%) |
| Mar 2019 | - | $2.19 M(+87.1%) |
| Dec 2018 | $1.17 M(+29.9%) | $1.17 M(-25.0%) |
| Sep 2018 | - | $1.56 M(-0.1%) |
| Jun 2018 | - | $1.56 M(+32.1%) |
| Mar 2018 | - | $1.18 M(+31.2%) |
| Dec 2017 | $898.50 K(-33.1%) | $898.50 K(-78.2%) |
| Sep 2017 | - | $4.12 M(+1.2%) |
| Jun 2017 | - | $4.07 M(+249.4%) |
| Mar 2017 | - | $1.17 M(-13.3%) |
| Dec 2016 | $1.34 M(+28.3%) | $1.34 M(+47.7%) |
| Sep 2016 | - | $909.30 K(+1.3%) |
| Jun 2016 | - | $897.80 K(-17.1%) |
| Mar 2016 | - | $1.08 M(+3.4%) |
| Dec 2015 | $1.05 M(+31.5%) | $1.05 M(-82.2%) |
| Sep 2015 | - | $5.89 M(+5.1%) |
| Jun 2015 | - | $5.60 M(+824.3%) |
| Mar 2015 | - | $606.00 K(-23.9%) |
| Dec 2014 | $796.30 K(-19.8%) | $796.30 K(+7.7%) |
| Sep 2014 | - | $739.50 K(-4.9%) |
| Jun 2014 | - | $777.90 K(-17.1%) |
| Mar 2014 | - | $938.10 K(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $992.80 K(-21.0%) | $992.80 K(-77.7%) |
| Sep 2013 | - | $4.45 M(+220.8%) |
| Jun 2013 | - | $1.39 M(+18.3%) |
| Mar 2013 | - | $1.17 M(-6.6%) |
| Dec 2012 | $1.26 M(-86.7%) | $1.26 M(-28.3%) |
| Sep 2012 | - | $1.75 M(-48.9%) |
| Jun 2012 | - | $3.43 M(+52.1%) |
| Mar 2012 | - | $2.26 M(-76.1%) |
| Dec 2011 | $9.45 M(+160.4%) | $9.45 M(+21.0%) |
| Sep 2011 | - | $7.81 M(+24.1%) |
| Jun 2011 | - | $6.29 M(+39.3%) |
| Mar 2011 | - | $4.52 M(+24.6%) |
| Dec 2010 | $3.63 M(+544.0%) | $3.63 M(+47.1%) |
| Sep 2010 | - | $2.46 M(+40.1%) |
| Jun 2010 | - | $1.76 M(+174.3%) |
| Mar 2010 | - | $641.50 K(+13.9%) |
| Dec 2009 | $563.20 K(-68.2%) | $563.20 K(-71.5%) |
| Sep 2009 | - | $1.97 M(-42.2%) |
| Jun 2009 | - | $3.41 M(+29.4%) |
| Mar 2009 | - | $2.64 M(+48.9%) |
| Dec 2008 | $1.77 M(+434.4%) | $1.77 M(+274.1%) |
| Sep 2008 | - | $473.50 K(+29.6%) |
| Jun 2008 | - | $365.40 K(-8.2%) |
| Mar 2008 | - | $398.10 K(+20.1%) |
| Dec 2007 | $331.50 K(+1.2%) | $331.50 K(+33.9%) |
| Sep 2007 | - | $247.60 K(-33.9%) |
| Jun 2007 | - | $374.70 K(+3.4%) |
| Mar 2007 | - | $362.40 K(+10.6%) |
| Dec 2006 | $327.60 K(-12.6%) | $327.60 K(+0.7%) |
| Sep 2006 | - | $325.30 K(-18.6%) |
| Jun 2006 | - | $399.80 K(+8.5%) |
| Mar 2006 | - | $368.40 K(-1.7%) |
| Dec 2005 | $374.80 K(-12.8%) | $374.80 K(-51.0%) |
| Sep 2005 | - | $764.60 K(-5.8%) |
| Jun 2005 | - | $812.10 K(-2.6%) |
| Mar 2005 | - | $833.90 K(+94.1%) |
| Dec 2004 | $429.60 K(+103.7%) | $429.60 K(+31.5%) |
| Sep 2004 | - | $326.80 K(+54.4%) |
| Jun 2004 | - | $211.70 K(+0.9%) |
| Mar 2004 | - | $209.80 K(-0.5%) |
| Dec 2003 | $210.90 K | $210.90 K(-10.8%) |
| Sep 2003 | - | $236.40 K(-29.3%) |
| Jun 2003 | - | $334.40 K |
FAQ
- What is Oragenics annual total liabilities?
- What is the all time high annual total liabilities for Oragenics?
- What is Oragenics annual total liabilities year-on-year change?
- What is Oragenics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Oragenics?
- What is Oragenics quarterly total liabilities year-on-year change?
What is Oragenics annual total liabilities?
The current annual total liabilities of OGEN is $1.80 M
What is the all time high annual total liabilities for Oragenics?
Oragenics all-time high annual total liabilities is $9.45 M
What is Oragenics annual total liabilities year-on-year change?
Over the past year, OGEN annual total liabilities has changed by +$49.50 K (+2.83%)
What is Oragenics quarterly total liabilities?
The current quarterly total liabilities of OGEN is $2.13 M
What is the all time high quarterly total liabilities for Oragenics?
Oragenics all-time high quarterly total liabilities is $9.45 M
What is Oragenics quarterly total liabilities year-on-year change?
Over the past year, OGEN quarterly total liabilities has changed by +$328.30 K (+18.26%)